News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
微創心通(02160.HK)ENO系列起搏器獲CE批准LBBAP適應症
微創心通-B(02160.HK)公布，近日，由集團自主研發的ENO系列心臟起搏器獲CE批准左束支區域起搏(LBBAP)適應症。至此，集團全系共六款CE認證起搏器均已獲批LBBAP適應症。(sl/da)~阿思達克財經新聞網址: www.aastocks.com
Reset
Send
The window will close in 5 seconds
微創心通(02160.HK)ENO系列起搏器獲CE批准LBBAP適應症
Close
Recommend
2
Positive
3
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get Level 1 Real-Time Streaming!

微創心通-B(02160.HK)  -0.070 (-3.153%)    Short selling $28.53K; Ratio 0.865%   公布，近日，由集團自主研發的ENO系列心臟起搏器獲CE批准左束支區域起搏(LBBAP)適應症。至此，集團全系共六款CE認證起搏器均已獲批LBBAP適應症。(sl/da)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-14 16:25.)

Switch to Auto-Translated Version
AASTOCKS新聞
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.